China SXT Pharmaceuticals

SXTC · NASDAQ

$0.072+$0.0067 (+10.26%)TodayMarket open · Oct 21, 10:30 AM ET · Delayed 15 min

Prev close $0.0653

About SXTC

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.

Employees: 75
Headquarters: Taizhou, Jiangsu
Listed: Jan 4, 2019
Sector: Health Care
Industry: Pharmaceuticals
Website: sxtchina.com

Leadership

China SXT Pharmaceuticals executives
Name	Title	Since	Age
Feng Zhou	—	2017	32
Lim Sze Beng	—	—	—
Xiaodong Pan	—	—	44
Jun Zheng	—	—	45
Xiaodong Ji	—	—	52
Tong Liu	—	—	43
Lip Chee Yong	—	—	—

Revenue by product and region

Fiscal year ended Mar 31, 2024: $1.93M total revenue

By product

Revenues generated from third parties$1.90M98.6%
Revenue generated from related parties$27.76K1.4%

Similar companies

Companies in the same industry as China SXT Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.